FORM 6

FORM 6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Report of Foreign Private Issuer

Pursuant to Rule 13a - 16 or 15d - 16 of

the Securities Exchange Act of 1934

 

For the month of May ,2004

Commission File Number: 1-10817

 

CELLTECH GROUP PLC

(Translation of registrant's name into English)

 

208 Bath Road, Slough, Berkshire SL1 3WE ENGLAND

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F X      Form 40-F

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes          No X

 

(If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-________).

 

 

Enclosure: Holding(s) in Company

 

SCHEDULE 10

NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Name of company
Celltech Group plc

2. Name of shareholder having a major interest
Franklin Resources, Inc. and its affiliates including Franklin Mutual Advisers, LLC and Templeton Worldwide, Inc. and its affiliates

3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18
As in 2 above

4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them

Bank of New York, Europe   860  
Chase NA London  4,153,689  
Citibank NA London  1,920  
Mellon Bank NA  357,708  
Northern Trust Company  760,125  
Royal Trust Corp of Canada  100,112  
State Street Nominees Limited  2,315,281  

5. Number of shares / amount of stock acquired
N/a

6. Percentage of issued class
N/a

7. Number of shares / amount of stock disposed
1,836,775 (since last notification)

8. Percentage of issued class
0.66%

9. Class of security
Ordinary 50p shares

10. Date of transaction
Unknown

11. Date company informed
21 May, 2004

12. Total holding following this notification
7,689,695

13. Total percentage holding of issued class following this notification
2.76%

14. Any additional information
NO LONGER HAVE A NOTIFIABLE INTEREST

15. Name of contact and telephone number for queries
Cheryl Cramer Tel. 01753 447933

16. Name and signature of authorised company official responsible for making this notification
J A D Slater

Date of notification
21 May, 2004

The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material contained in it, or from any action or decision taken as a result of using this document or any such material.

SCHEDULE 10

NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Name of company
Celltech Group plc

2. Name of shareholder having a major interest
The Capital Group Companies, Inc.

3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18
As in 2 above

4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them

State Street Nominees Ltd   4,500  
Chase Nominees Ltd  1,772,403  
Citibank London  74,300  
Nortrust Nominees  785,500  
Mellon Nominees (UK) Ltd  126,900  
State Street Nominees Ltd  228,200  
Bank of New York Nominees  2,829,001  
Northern Trust  598,302  
Chase Nominees Ltd  1,106,963  
Midland Bank plc  68,000  
Bankers Trust  136,900  
Morgan Guaranty  161,400  
Nortrust Nominees  1,619,238  
Royal Bank of Scotland  652,800  
State Street Bank & Trust Co  82,600  
Deutsche Bank AG  663,700  
HSBC Bank plc  490,500  
Mellon Bank N.A  18,300  
KAS UK  44,310  
Bank One London  47,700  
State Street Nominees Ltd  58,000  
Chase Nominees Ltd  2,223,691  
Midland Bank plc  525,900  
Barclays Bank  566,900  
Citibank London  23,700  
Brown Bros  34,230  
Royal Bank of Scotland  365,800  
State Street Bank & Trust Co.  53,400  
Lloyds Bank  60,000  
RBSTB Nominees Ltd  104,800  
Citibank NA  17,600  
HSBC Bank plc  398,409  
State Street Nominees Ltd  753,400  
Bank of New York Nominees  26,600  
Chase Nominees Ltd  92,000  
Midland Bank plc  153,700  
Deutsche Bank Mannheim  24,000  
Bankers Trust  4,900  
Citibank London  21,000  
Nortrust Nominees  426,823  
Royal Bank of Scotland  129,500  
State Street Bank & Trust Co  319,900  
RBSTB Nominees Ltd  26,300  
HSBC Bank plc  120,700  

5. Number of shares / amount of stock acquired
N/a

6. Percentage of issued class
N/a

7. Number of shares / amount of stock disposed
6,136,455 (since last notification)

8. Percentage of issued class
2.205%

9. Class of security
Ordinary 50p Shares

10. Date of transaction
20 May 2004

11. Date company informed
21 May 2004

12. Total holding following this notification
18,042,770

13. Total percentage holding of issued class following this notification
6.484%

14. Any additional information
-

15. Name of contact and telephone number for queries
Cheryl Cramer 01753 447933

16. Name and signature of authorised company official responsible for making this notification
J A D Slater

Date of notification
24 May 2004

The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material contained in it, or from any action or decision taken as a result of using this document or any such material.

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

                                                                                                                                                           CELLTECH GROUP PLC
                                                                                                                                                           (Registrant)

 

 

                                                                                                                                                           By: /s/ PETER ALLEN       
                                                                                                                                                           Peter Allen
                                                                                                                                                           Chief Financial Officer

 

Dated: 24 May, 2004